-
Progression of parkinsonian signs in Alzheimer's disease.
Neurology. 2000 Mar 28;54(6):1284-9
PMID: 10746599
-
Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX.
Neurology. 1999 Jun 10;52(9):1839-44
PMID: 10371532
-
An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer disease.
Arch Neurol. 2001 Mar;58(3):460-5
PMID: 11255450
-
Effect of extrapyramidal signs and Lewy bodies on survival in patients with Alzheimer disease.
Arch Neurol. 2002 Apr;59(4):588-93
PMID: 11939893
-
Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease.
Neurology. 2002 Apr 23;58(8):1182-8
PMID: 11971084
-
Apolipoprotein E epsilon 4 in an autopsy series of various dementing disorders.
J Alzheimers Dis. 2003 Apr;5(2):119-25
PMID: 12719629
-
The impact of parkinsonism on costs of care in patients with AD and dementia with Lewy bodies.
Neurology. 2003 Oct 14;61(7):944-9
PMID: 14557565
-
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.
Br J Psychiatry. 1968 Jul;114(512):797-811
PMID: 5662937
-
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.
J Psychiatr Res. 1975 Nov;12(3):189-98
PMID: 1202204
-
Depression, intellectual impairment, and Parkinson disease.
Neurology. 1981 Jun;31(6):645-50
PMID: 7195481
-
Striatal dopamine receptors in Alzheimer-type dementia.
Neurosci Lett. 1984 Nov 23;52(1-2):1-6
PMID: 6241300
-
Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients.
Neurology. 1987 May;37(5):754-60
PMID: 3033544
-
Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease.
Neurobiol Aging. 1988 May-Jun;9(3):245-52
PMID: 3398991
-
Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.
Ann Neurol. 1988 Jul;24(1):50-6
PMID: 3415200
-
Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors?
Arch Neurol. 1989 Jun;46(6):651-7
PMID: 2730377
-
The prognosis in Alzheimer's disease. 'How far' rather than 'how fast' best predicts the course.
Arch Neurol. 1990 Aug;47(8):851-6
PMID: 2375690
-
Clinical and positron emission tomographic studies in the 'extrapyramidal syndrome' of dementia of the Alzheimer type.
Arch Neurol. 1990 Dec;47(12):1318-23
PMID: 2252449
-
Neurological signs in Alzheimer's disease.
Age Ageing. 1991 Jan;20(1):45-51
PMID: 2028851
-
Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.
Arterioscler Thromb. 1991 Sep-Oct;11(5):1237-44
PMID: 1680392
-
Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease.
Arch Neurol. 1991 Nov;48(11):1141-3
PMID: 1953398
-
Interrater reliability of extrapyramidal signs in a group assessed for dementia.
Arch Neurol. 1991 Nov;48(11):1147-9
PMID: 1953399
-
Cognitive decline in patients with Alzheimer disease: differences in patients with and without extrapyramidal signs.
Alzheimer Dis Assoc Disord. 1991 Winter;5(4):251-6
PMID: 1781967
-
Extrapyramidal signs in Alzheimer's disease: a 3-year follow-up study.
J Neural Transm Park Dis Dement Sect. 1992;4(2):107-19
PMID: 1349210
-
Operational criteria for senile dementia of Lewy body type (SDLT).
Psychol Med. 1992 Nov;22(4):911-22
PMID: 1362617
-
Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). I. Study design, cohort description, and intersite comparisons.
Alzheimer Dis Assoc Disord. 1993 Spring;7(1):3-21
PMID: 8481224
-
'How far' vs 'how fast' in Alzheimer's disease. The question revisited.
Arch Neurol. 1994 Mar;51(3):275-9
PMID: 8129639
-
Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease.
Arch Neurol. 1994 Jul;51(7):676-81
PMID: 8018040
-
Apolipoprotein-E epsilon-4 is associated with increased neurofibrillary pathology in the Lewy body variant of Alzheimer's disease.
Neurosci Lett. 1994 Nov 21;182(1):63-5
PMID: 7891889
-
Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
Ann Neurol. 1995 Mar;37(3):300-12
PMID: 7695230
-
Study of Alzheimer's dementia patients with parkinsonian features.
J Geriatr Psychiatry Neurol. 1995 Jul;8(3):154-8
PMID: 7576038
-
Comorbidity and its effect on mortality in nursing home patients with dementia.
J Nerv Ment Dis. 1996 Mar;184(3):180-7
PMID: 8600222
-
Clinical features and mortality in patients with early-onset Alzheimer's disease.
Eur Neurol. 1996;36(2):103-6
PMID: 8654478
-
The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant.
Neurology. 1996 Jul;47(1):190-6
PMID: 8710076
-
Extrapyramidal motor signs in clinically diagnosed Alzheimer disease.
Alzheimer Dis Assoc Disord. 1996 Summer;10(2):103-14
PMID: 8727172
-
Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases.
Am J Psychiatry. 1996 Oct;153(10):1269-73
PMID: 8831433
-
Pathological correlates of extrapyramidal signs in Alzheimer's disease.
Ann Neurol. 1997 Mar;41(3):368-74
PMID: 9066358
-
The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease.
Ann Neurol. 1997 May;41(5):615-20
PMID: 9153523
-
Extrapyramidal signs in patients with probable Alzheimer disease.
Arch Neurol. 1997 Aug;54(8):969-75
PMID: 9267971
-
Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale.
Neurology. 1997 Dec;49(6):1580-7
PMID: 9409350
-
Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.
Neurology. 1998 Aug;51(2):351-7
PMID: 9710002
-
Progression of parkinsonian signs in Parkinson disease.
Arch Neurol. 1999 Mar;56(3):334-7
PMID: 10190824
-
The association between parkinsonism, Alzheimer's disease, and mortality: a comprehensive approach.
J Am Geriatr Soc. 2000 Apr;48(4):422-5
PMID: 10798470